STAGE IIIA CERVICAL CANCER FIGO 2018
Clinical trials for STAGE IIIA CERVICAL CANCER FIGO 2018 explained in plain language.
Never miss a new study
Get alerted when new STAGE IIIA CERVICAL CANCER FIGO 2018 trials appear
Sign up with your email to follow new studies for STAGE IIIA CERVICAL CANCER FIGO 2018, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to shrink cervical cancer before radiation
Disease control Recruiting nowThis study tests whether adding a round of chemotherapy and the immunotherapy drug pembrolizumab before the usual chemoradiation can help people with high-risk, locally advanced cervical cancer live longer without the disease getting worse. About 336 participants will be randomly…
Matched conditions: STAGE IIIA CERVICAL CANCER FIGO 2018
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 08, 2026 13:08 UTC
-
New asian registry aims to improve cervical cancer radiation treatment
Knowledge-focused Recruiting nowThis study is creating a registry to collect information from hospitals across Asia on how brachytherapy (internal radiation) is used to treat cervical cancer. The goal is to understand current practices, track outcomes, and find ways to improve care for women with this disease. …
Matched conditions: STAGE IIIA CERVICAL CANCER FIGO 2018
Sponsor: Tata Memorial Hospital • Aim: Knowledge-focused
Last updated Jun 08, 2026 13:18 UTC